Key result
Pregnancy hypertension and preeclampsia are linked to up to ~110% higher long-term VTE risk.
Why the study?
Whether hypertension during pregnancy and preeclampsia are associated with venous thromboembolism risk in the short term after pregnancy and on the long term outside pregnancy was largely unknown.
Do hypertensive complications of pregnancy (hypertension or preeclampsia) increase the risk of venous thromboembolism in women with at least 1 pregnancy?
Cohort (n=1,919,918)
Yes
Do hypertensive complications of pregnancy (hypertension or preeclampsia) increase the risk of venous thromboembolism in women with at least 1 pregnancy?
Effect estimate: HR 2.1 (95% CI 1.8-2.4)
Hypertension during pregnancy and preeclampsia are associated with a significantly increased risk of venous thromboembolism both during the peripartum period and up to 13 years later.
May warrant heightened VTE vigilance after hypertensive pregnancies; leaves open whether targeted prophylaxis improves outcomes.
Hypertension during pregnancy and preeclampsia are associated with increased arterial thrombotic risk in later life. Whether these complications are associated with risk of venous thromboembolism (VTE) on the short term after pregnancy and on the long term, that is, outside pregnancy, is largely unknown. We conducted a nationwide cohort study in women with at least 1 pregnancy and their first VTE risk by linking the Dutch perinatal registry (Perined) to anticoagulation clinics. We used Cox proportional hazard models to estimate hazard ratios (HRs) and corresponding 95% CI for VTE risk in women with hypertension during pregnancy, women with preeclampsia, compared with women with uncomplicated pregnancies (reference). A total of 1 919 918 women were followed for a median of 13.7 (interquartile range, 7.6-19.2) years for a total of 24 531 118 person-years in which 5759 first VTEs occurred; incidence rate: 2.3 (95% CI, 2.3-2.4) per 10 000 person-years. In the first pregnancy and 3-month postpartum period, VTE risk was higher in women with hypertension, HR, 2.0 (95% CI, 1.7-2.4), and highest among women with preeclampsia, HR, 7.8 (95% CI, 5.4-11.3), versus the reference group. On the long term, women with hypertension during pregnancy and preeclampsia had a higher VTE risk: HR, 1.5 (95% CI, 1.4-1.6) and HR, 2.1 (95% CI, 1.8-2.4), respectively, versus the reference group. When excluding events during pregnancy and postpartum, these HRs were 1.4 (95% CI, 1.3-1.5) and 1.6 (95% CI, 1.4-2.0), respectively. In conclusion, hypertension during pregnancy and preeclampsia are associated with an increased VTE risk during pregnancy and postpartum period and in the 13 years after.
No takes yet. Share an insight, caveat, or question.
Scheres et al. (2020) conducted a cohort in Hypertension during pregnancy and preeclampsia (n=1,919,918). Hypertension during pregnancy and preeclampsia vs. Uncomplicated pregnancies was evaluated on First venous thromboembolism (VTE) (HR 2.1, 95% CI 1.8-2.4). Hypertension during pregnancy and preeclampsia were associated with an increased long-term risk of venous thromboembolism compared with uncomplicated pregnancies (HR 1.5 and HR 2.1, respectively).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: